Log in to save to my catalogue

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell...

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890277

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer

About this item

Full title

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer

Publisher

England: BioMed Central Ltd

Journal title

BMC cancer, 2016-06, Vol.16 (1), p.348-348, Article 348

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Radical treatment for oligometastatic non-small-cell lung cancer (NSCLC) has a curative potential for selected patients. The present retrospective study was designed to examine the relevance of synchronous vs. metachronous manifestations as a potential prognostic factor when ablative treatments are performed in oligometastatic disease.
Seventy-f...

Alternative Titles

Full title

Long-term outcomes in radically treated synchronous vs. metachronous oligometastatic non-small-cell lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890277

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890277

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-016-2379-x

How to access this item